Metastatic Adenocarcinoma of the Gastroesophageal Junction
2 clinical trials · Condition
◉ Watch Metastatic Adenocarcinoma of the Gastroesophageal Junction
| Record | Firm | Date |
|---|---|---|
| Ramucirumab Plus TAS-102 in Patients With Advanced or Metastatic Gastric Adenocarcinoma or the Gastroesophageal Junction (NCT04517747) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-10-15 |
| International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer (NCT02065765) | Eli Lilly and Company |
Track Metastatic Adenocarcinoma of the Gastroesophageal Junction automatically
Every clearance here is in the API, with alerts when new ones post.